Clinical Trials Directory

Trials / Completed

CompletedNCT01705639

Melatonin and Glucose Tolerance Among Individuals With a Variant of the MTNR1B Gene

Does Melatonin Treatment Affect Glucose Tolerance Among Individuals With a Variant (rs10830963) of the Melatonin Receptor 1B (MTNR1B) Gene?

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
45 (actual)
Sponsor
University of Helsinki · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

The effect of 3 months of melatonin 4mg treatment on glucose tolerance in different variants of the melatonin receptor 1B gene will be evaluated. The following will be done at 0 and 3 months: * OGTT * questionnaires about sleep and activity * Actigraph * Anthropometry * Blood pressure

Detailed description

http://www.sciencedirect.com/science/article/pii/S1550413116301607

Conditions

Interventions

TypeNameDescription
DRUGMelatoninAll subjects receive the same dose of melatonin

Timeline

Start date
2012-11-01
Primary completion
2014-08-01
Completion
2014-08-01
First posted
2012-10-12
Last updated
2017-01-04

Locations

2 sites across 1 country: Finland

Source: ClinicalTrials.gov record NCT01705639. Inclusion in this directory is not an endorsement.

Melatonin and Glucose Tolerance Among Individuals With a Variant of the MTNR1B Gene (NCT01705639) · Clinical Trials Directory